Gilead Sciences Inc (GILD)
74.95
-0.47
(-0.62%)
USD |
NASDAQ |
Sep 29, 16:00
74.93
-0.02
(-0.03%)
After-Hours: 20:00
Gilead Sciences Price to Book Value: 4.414 for Sept. 29, 2023
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
September 29, 2023 | 4.414 |
September 28, 2023 | 4.442 |
September 27, 2023 | 4.449 |
September 26, 2023 | 4.448 |
September 25, 2023 | 4.407 |
September 22, 2023 | 4.418 |
September 21, 2023 | 4.433 |
September 20, 2023 | 4.465 |
September 19, 2023 | 4.462 |
September 18, 2023 | 4.454 |
September 15, 2023 | 4.456 |
September 14, 2023 | 4.556 |
September 13, 2023 | 4.553 |
September 12, 2023 | 4.523 |
September 11, 2023 | 4.537 |
September 08, 2023 | 4.476 |
September 07, 2023 | 4.355 |
September 06, 2023 | 4.372 |
September 05, 2023 | 4.426 |
September 01, 2023 | 4.514 |
August 31, 2023 | 4.504 |
August 30, 2023 | 4.574 |
August 29, 2023 | 4.606 |
August 28, 2023 | 4.537 |
August 25, 2023 | 4.527 |
Date | Value |
---|---|
August 24, 2023 | 4.495 |
August 23, 2023 | 4.537 |
August 22, 2023 | 4.496 |
August 21, 2023 | 4.472 |
August 18, 2023 | 4.469 |
August 17, 2023 | 4.505 |
August 16, 2023 | 4.594 |
August 15, 2023 | 4.690 |
August 14, 2023 | 4.703 |
August 11, 2023 | 4.712 |
August 10, 2023 | 4.712 |
August 09, 2023 | 4.722 |
August 08, 2023 | 4.716 |
August 07, 2023 | 4.751 |
August 04, 2023 | 4.634 |
August 03, 2023 | 4.448 |
August 02, 2023 | 4.457 |
August 01, 2023 | 4.457 |
July 31, 2023 | 4.484 |
July 28, 2023 | 4.530 |
July 27, 2023 | 4.510 |
July 26, 2023 | 4.550 |
July 25, 2023 | 4.552 |
July 24, 2023 | 4.577 |
July 21, 2023 | 4.753 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.426
Minimum
Dec 24 2018
5.431
Maximum
Jul 20 2020
4.231
Average
4.200
Median
Price to Book Value Benchmarks
Pfizer Inc | 1.891 |
AbbVie Inc | 20.45 |
Biogen Inc | 2.573 |
Amgen Inc | 21.20 |
Moderna Inc | 2.319 |
Price to Book Value Related Metrics
PE Ratio | 17.23 |
PS Ratio | 3.452 |
PEG Ratio | 0.5282 |
Price to Free Cash Flow | 10.59 |
Price | 74.95 |
Earnings Yield | 5.80% |
Market Cap | 93.39B |
PEGY Ratio | 0.4708 |
Operating PE Ratio | 7.565 |
Normalized PE Ratio | 10.96 |